Giusy Cetani
Caserta, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.
Journal: Hematological oncology
Published: September 02, 2025
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Journal: European journal of haematology
Published: July 23, 2024
Epigenetic challenges on the horizon of chimeric antigen receptor-T.
Journal: Cytotherapy
Published: November 27, 2023
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
Journal: Targeted oncology
Published: September 08, 2023
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Journal: Cancers
Published: February 18, 2021
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients.
Journal: Frontiers in cardiovascular medicine
Published: December 23, 2020
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.
Journal: Annals of hematology
Published: June 16, 2020
Moving Toward Continuous Therapy in Multiple Myeloma.
Journal: Clinical hematology international
Published: September 16, 2019
A look at treatment strategies for relapsed multiple myeloma.
Journal: Expert review of anticancer therapy
Published: May 17, 2018
Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.
Journal: Current medicinal chemistry
Published: December 27, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026